close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Home・Aandelen Lijst・Clearside Biomedical Inc
Search

Clearside Biomedical Inc

Gesloten

0

Neutraal

Prijsupdate 1 jan 1970, 00:00 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken

By Trading Economics

Inkomsten

-1.5M

-6M

Verkoop

-291K

201K

EPS

-1.14

Winstmarge

-2,971.144

Werknemers

32

EBITDA

-1.7M

-3.3M

Dividenden

By Dow Jones

Volgende Winsten

26 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-17M

2.1M

Vorige openingsprijs

0

Vorige sluitingsprijs

0

Technische score

By Trading Central

Vertrouwen

Neutral Evidence

0.8417 / 0.8939 Steun & Weerstand

Clearside Biomedical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 feb 2026, 23:07 UTC

Winsten

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

DJ

Lezen

24 feb 2026, 23:01 UTC

Winsten

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

DJ

Lezen

24 feb 2026, 22:59 UTC

Winsten

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

DJ

Lezen

24 feb 2026, 22:42 UTC

Winsten

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

DJ

Lezen

24 feb 2026, 22:24 UTC

Acquisities, Fusies, Overnames

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

DJ

Lezen

24 feb 2026, 23:46 UTC

Marktinformatie

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

DJ

Lezen

24 feb 2026, 23:36 UTC

Marktinformatie

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

DJ

Lezen

24 feb 2026, 23:30 UTC

Marktinformatie

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

DJ

Lezen

24 feb 2026, 23:20 UTC

Marktinformatie

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

DJ

Lezen

24 feb 2026, 23:20 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

24 feb 2026, 23:16 UTC

Winsten

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

DJ

Lezen

24 feb 2026, 23:13 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

DJ

Lezen

24 feb 2026, 23:12 UTC

Winsten

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

DJ

Lezen

24 feb 2026, 23:10 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

DJ

Lezen

24 feb 2026, 23:10 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

DJ

Lezen

24 feb 2026, 23:08 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

DJ

Lezen

24 feb 2026, 23:07 UTC

Winsten

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

DJ

Lezen

24 feb 2026, 22:52 UTC

Winsten

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

DJ

Lezen

24 feb 2026, 22:46 UTC

Winsten

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

DJ

Lezen

24 feb 2026, 22:31 UTC

Acquisities, Fusies, Overnames

Warner Receives New Bid From Paramount -- 3rd Update

DJ

Lezen

24 feb 2026, 22:29 UTC

Winsten

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

DJ

Lezen

24 feb 2026, 22:28 UTC

Winsten

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

DJ

Lezen

24 feb 2026, 22:27 UTC

Winsten

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

DJ

Lezen

24 feb 2026, 22:27 UTC

Winsten

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

DJ

Lezen

24 feb 2026, 22:25 UTC

Winsten

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

DJ

Lezen

24 feb 2026, 22:24 UTC

Winsten

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

DJ

Lezen

24 feb 2026, 22:23 UTC

Winsten

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

DJ

Lezen

24 feb 2026, 22:22 UTC

Winsten

Woolworths Interim Dividend 45 Australian Cents/Share

DJ

Lezen

24 feb 2026, 22:22 UTC

Winsten

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

DJ

Lezen

24 feb 2026, 22:21 UTC

Winsten

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

DJ

Lezen

Peer Vergelijking

Prijswijziging

Clearside Biomedical Inc Prognose

Beoordelingsconsensus

By TipRanks

Neutraal

1 ratings

0

Buy

1

Hold

0

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Clearside Biomedical Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

0.8417 / 0.8939Steun & Weerstand

Korte Termijn

Neutral Evidence

The bullish and bearish events are balanced.

Gemiddeld Termijn

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Lange Termijn

Weak Bearish Evidence

There is one bearish event.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,042.27

↓-1.11%

JNJ

Johnson and Johnson

246.2

↑ +0.25%

ABBV

AbbVie Inc

228.42

↓-0.4%

NVS

Novartis AG

166.68

↑ +1.33%

MRK

Merck & Co Inc.

123.89

↑ +0.15%
help-icon Live chat